Skip to main content

Lineage Cell Therapeutics, Inc 10-Q for FY2025 Q3

Lineage Cell Therapeutics, Inc. (LCTX)

10-Q 2025-11-06 For: 2025-09-30
View Original
Added on April 12, 2026

About this 10-Q

Lineage Cell Therapeutics, Inc filed this 10-Q on November 6, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).

Headline figures

Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$3.68M
down 2.6% from $3.78M a year earlier
Net loss
$29.78M
compared with a net loss of $3.03M a year earlier
Diluted EPS
-$0.13
compared with -$0.02 a year earlier